NCT06396819

Collagen-povidone for Diabetic Seniors' Tenosynovitis

Name: Clinical Trial NCT06396819
Creator: Instituto Mexicano del Seguro Social
Keywords: Diabetes Complications, collagen-povidone solution, Phase 4, drug, clinical trial, Mexico

Topical Collagen-povidone Injection as an Alternative Treatment for Stenosing Tenosynovitis in Older Adults With Type 2 Diabetes Mellitus

Instituto Mexicano del Seguro Social·Phase 4·ClinicalTrials.gov·drugCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Diabetes Complications
Drug/Device/Intervention: collagen-povidone solution
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Instituto Mexicano del Seguro Social
Location: Guadalajara, Mexico

Timeline & enrollment

Phase: Phase 4
Start date: Jan 01, 2023
End date: Apr 01, 2024
Enrollment: 25 participants

Primary outcome

Mean evolution time of tenosynovitis

Summary

Diabetes affects 415 million adults globally, leading to hand issues. Povidone collagen shows promise in managing tenosynovitis. A clinical trial was conduced to compared its efficacy in adults over 60. It is shown that the intervention reduces pain, improves functionality, and grip strength with no complications. Collagen povidone holds potential for treating diabetic hand issues.

ICD-10 classifications

Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06396819
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06396819 through Pure Global AI's free database. This Phase 4 trial is sponsored by Instituto Mexicano del Seguro Social and is currently Completed. The study focuses on Diabetes Complications. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.